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“Therefore, a Neurologist needs to always be cog-
nizant of the fact that neurological manifestations, 
could be resulting from Neuroborrelial mimicry”
It has been stated, “Like its close spirochetal cousin 
Treponema pallidum (the bacterium that causes syphilis), B. 
burgdorferi can cause disabling neurologic manifestations and present a puzzling diagnostic challenge” [1].
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Coyle noted that in Lyme disease, “neurological involve-ment occurs in up to 40% of symptomatic infections and includes both CNS and PNS involvement” [2].The literature further states that, “Many healthcare practitioners mistakenly believe LD (Lyme disease) is not endemic to their state (in USA), causing them to omit the diagnosis from their differential or discount the patient’s concerns in this regard.  Unfortunately, practitioners may not realize that LD has been found in every state.  In states where B. burgdorferi carrying ticks are not highly prevalent, the ticks may be carried in on the bodies of birds, pets, wild animals, or people. Furthermore, practitioners often do not obtain a thorough patient travel history that might raise suspicion to test for LD” [1,2,3]. The literature also points out that, “Some LD patients are misdiagnosed with serious, untreatable chronic conditions (i.e. ALS, MS, Early Onset Alzheimer’s Disease, Epilepsy, Par-kinson Disease) with no hope for recovery. When patients 
are assumed to have an autoimmune disease, they are even put on corticosteroids to suppress their immune system, an unfortunate outcome for a patient with a chronic infection” [1,2].The emotional trauma to patients and their loved ones that result when Lyme Neuroborreliosis has been misdiag-nosed with an untreatable neurological disease is devastat-ing!! Thus, the greatest effort must be made by a Neurolo-gist to avoid such a misdiagnosis.
The noted country and western music star Kris Krist-offerson has become a Poster Child for Lyme Neurobor-reliosis which had misdiagnosed as Alzheimer’s Disease (CBSNews July 2. 2016: Kris Kristofferson’s Lyme disease misdiagnosed as Alzheimer’s).
In Virginia Savely’s monograph on the diagnostic dilem-ma posed by Lyme Disease, the author states that “patients are often labeled “atypical” in their disease presentation, meaning that their disease process greatly resembles the given diagnosis but is missing some of the diagnostic fea-tures. Anyone with an atypical presentation of any of the diseases discussed below should be thoroughly evaluated to rule out the possibility of disseminated LD” [1]. There-fore, a Neurologist needs to always be cognizant of the fact that neurological manifestations, could be resulting from Neuroborrelial mimicry [1-4]. 
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06The problems associated misdiagnosis as relates Lyme Disease were considered so serious a concern that, when the Department of Health of the Commonwealth of Penn-sylvania (I was a member of this special committee) con-vened the special Task Force Committee on Tick and Lyme Disease in August of 2014 (the Pa Task Force group worked from Sept 2014 to Sept 2015). To create guidelines and recommendations on how the Pennsyvlania deal with the 
ramifications associated with Lyme Disease and related tick borne infections, Misdiagnosis was discussed by the special task force committee and recommendations were put for-ward in order to promote a of general awareness for both the public and healthcare professionals on the long-term ef-fects of misdiagnosis of Lyme Disease and its many serious 
ramifications.  
Makhani., et al. have stated that “There is no “gold stan-dard” diagnostic test for Lyme Neuroborreliosis. Direct cul-ture of Borrelia species and PCR are of low sensitivity; there-fore, laboratory diagnosis instead relies on the detection of anti-Borrelia antibodies [5]. In North America, testing follows a two-step algorithm. Serum samples are screened for antibodies with an ELISA, a relatively sensitive, but not 
specific test. Confirmatory testing is then performed using 
Western blotting, which is specific, but not sensitive. The sensitivity of the two-step approach is well described to in-crease in later stages of the disease for both European and North American acquired borreliosis. While sensitivity may be less than 40% in cases of acute stage 1 Lyme disease, both retrospective and prospective studies from New En-gland have found the sensitivity of the two-step approach to be 85% to 100% in cases of stage 2 acute “Neuroborreli-
Dersche., et al. stated that, “Patients with LNB and neu-
rosyphilis showed significantly higher CXCL13 levels in their CSF compared to MS patients (p < 0.05, p < 0.001, re-
spectively). CXCL13 levels in the CSF declined during treat-ment” [6].
Research investigations as relates to the development of accurate lab based assays as relates to improved early and accurate detection of Neuroborrelial infections and the 
ability to monitor the efficacy of therapy as a function of 
changes in the pathogen load and eventual clearance of the pathogen from the patient are needed.  
Borrelial pathogens like their cousin Treponema pall-
idum can mimic a variety of illnesses and can invade the CNS [3]. It is therefore incumbent upon all Neurologists to be ready to think “out of the box” when it comes to consid-ering the possibility of a potential microbial agent as the “raison d’être” of Neuropathology whether one practices in a known endemic or non-endemic region for infections such as Lyme Neuroborreliosis which is commonly associ-ated with tick bites, but can be also transmitted by other non-tick related vectors.
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